miR-503 was found underexpressed in hepatocellular carcinoma (HCC) and was shown to inhibit angiogenesis in vitro and in vivo by downregulating expression of both fibroblast growth factor 2 (FGF2) and vascular growth factor A (VEGFA) (75). This evidence concerns the gene VEGFA and hepatocellular carcinoma.